Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Ritter

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
Pageof 6